IXALTIS
Ixaltis is a pharmaceutical company that develops therapeutics to treat genitourinary disorders with unsatisfied medical needs. The company was born out of the combined expertise of scientists specialized in urology, pharmaceutical experts and experienced managers: Dr. Philippe Lluel, Christian Chavy, Stefano Palea, Dr. Roberto Gradnik and Professors Pascal Rischmann and Xavier Gamé. The vision of IXALTIS is to develop treatments for genito-urinary tract diseases with still a high unmet medical need, by identifying drugs which had already reached clinical stage and reexplore these for use in genitourinary tract disorders. IXALTIS has established a proprietary position covering Litoxetine for use in urogenital and other disorders based on its specific mechanism of action.
IXALTIS
Industry:
Biopharma Biotechnology Health Care Medical Medical Device Pharmaceutical Therapeutics
Founded:
2012-01-01
Address:
Toulouse, Midi-Pyrenees, France
Country:
France
Website Url:
http://www.ixaltis.com
Total Employee:
11+
Status:
Active
Contact:
+33 (0)4 57 26 00 76
Email Addresses:
[email protected]
Total Funding:
8 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Apple Mobile Web Clips Icon WordPress Apache Wordpress Plugins IPv6 Google Apps For Business Google Maps
Current Employees Featured
Founder
Investors List
IXO Private Equity
IXO Private Equity investment in Venture Round - Ixaltis
Principia SGR
Principia SGR investment in Venture Round - Ixaltis
Pierre Olivier Goineau
Pierre Olivier Goineau investment in Venture Round - Ixaltis
IRDI
IRDI investment in Venture Round - Ixaltis
Sofimac Investment Managers
Sofimac Investment Managers investment in Venture Round - Ixaltis
Official Site Inspections
http://www.ixaltis.com
- Host name: gpaas2.dc0.gandi.net
- IP address: 217.70.180.132
- Location: Paris France
- Latitude: 48.8543
- Longitude: 2.3527
- Timezone: Europe/Paris
- Postal: 75000
